| 摘要 |
A compound selected from those of formula (I): wherein: R<SUB>3 </SUB>represents a hydrogen atom, and R<SUB>1 </SUB>and R<SUB>2 </SUB>together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, or R<SUB>1 </SUB>represents a hydrogen atom, and R<SUB>2 </SUB>and R<SUB>3 </SUB>together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, n represents 1 or 2, -X- represents a group selected from -(CH<SUB>2</SUB>)<SUB>m</SUB>-O-Ak-, -(CH<SUB>2</SUB>)<SUB>m</SUB>-NR<SUB>4</SUB>-Ak-, -(CO)-NR<SUB>4</SUB>-Ak- and -(CH<SUB>2</SUB>)<SUB>m</SUB>-NR<SUB>4</SUB>-(CO)-, m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R<SUB>4 </SUB>represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid. Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK<SUB>1 </SUB>antagonist.
|
